FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, namely dermatology and clinical laboratory diagnostics, and concerns a method for evaluating the effectiveness of the standard therapy in the patients with numular microbial eczema, which involves determining on 10th day of therapy in venous blood the level of T-lymphocyte-helpers and cytotoxic T-lymphocytes. At their values of 0.6×109/l and lower treatment efficiency is considered to be low, and at 0.7×109/l and higher as high.
EFFECT: use of the invention improves the accuracy of the evaluation of the effectiveness of standard therapy, simplifies the study.
1 cl, 1 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING THE TRANSITION OF THE MEDIUM-HEAVY COURSE OF THE NUMMULAR MICROBIAL ECZEMA INTO THE SEVERE COURSE | 2019 |
|
RU2702236C1 |
METHOD OF EVALUATING THE CLINICAL EFFECTIVENESS OF NUMMULAR MICROBIAL ECZEMA | 2018 |
|
RU2695071C1 |
METHOD FOR PREDICTING THE TRANSITION OF MODERATELY SEVERE NUMMULAR MICROBIAL ECZEMA TO SEVERE ONE | 2018 |
|
RU2681656C1 |
METHOD FOR ESTIMATING THE EFFICIENCY OF STANDARD THERAPY AMONG PATIENTS WITH NUMULAR MICROBIAL ECZEMA | 2018 |
|
RU2677881C1 |
METHOD FOR PREDICTING THE TRANSITION OF A MODERATE COURSE OF NUMMULAR MICROBIAL ECZEMA INTO A SEVERE COURSE | 2018 |
|
RU2692797C1 |
METHOD OF YERSINIOSIS INFECTION TREATMENT FOR CHILDREN | 2007 |
|
RU2371174C2 |
METHOD OF TREATING DISSEMINATED LICHEN ACUMINATUS ASSOCIATED WITH CHRONIC GRANULOMATOUS PERIODONTITIS | 2019 |
|
RU2703313C1 |
METHOD FOR INDIVIDUAL PREDICTION OF DETERIORATION PROBABILITY OF CLINICAL COURSE OF ECZEMA, PROGRESSION INTO ERYTHRODERMA | 2012 |
|
RU2508901C1 |
METHOD OF TREATING Helicobacter pylori ASSOCIATED CHRONIC ULCEROUS DISEASE OF STOMACH AND DUODENUM | 2010 |
|
RU2416408C1 |
METHOD FOR PREDICTION OF THE RISK OF INFECTIOUS COMPLICATIONS IN ATOPIC DERMATITIS | 2018 |
|
RU2694223C1 |
Authors
Dates
2019-09-05—Published
2019-05-08—Filed